|
Quotes & Info
|
| BPTH > SEC Filings for BPTH > Form 8-K on 26-Jul-2012 | All Recent SEC Filings |
26-Jul-2012
Other Events, Financial Statements and Exhibits
On July 25, 2012, Bio-Path Holdings, Inc. issued a press release titled "Bio-Path Holdings Begins Enrollment in Fourth Cohort of Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia."
A copy of such press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(d) Exhibits.
Exhibit Number Description 99.1 Press Release dated July 25, 2012 |
|
|